The RITUXAN for RA EXPERIENCE Program

 

through Genentech
Rheumatology
Access Solutions

$4,000 per
12-month period
toward the cost of
Rituxan for eligible patients

Learn More

Indication

Rituxan® (rituximab) in combination with methotrexate is indicated for the treatment of adult patients with moderately to severely- active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.

Rituxan is not recommended for treatment of patients with severe active infections.

Important Safety Information

RITUXAN administration can result in serious, including fatal, adverse reactions. These include: infusion reactions, tumor lysis syndrome (TLS), severe mucocutaneous reactions, and progressive multifocal leukoencephalopathy (PML).

Warnings and Precautions

Rituxan administration can also result in additional serious, including fatal, adverse reactions including:

  • hepatitis B reactivation
  • other infections including bacterial, fungal, new or reactivated viral infections
  • cardiovascular events

Patients should be closely observed for signs of infection if biologic agents and /or DMARDs other than methotrexate are used concomitantly

Common adverse reactions include infusion reactions and infections

For additional safety information, please see the full prescribing information, including BOXED WARNINGS and Medication Guide.

Attention Healthcare Provider: Provide Medication Guide to patient prior to RITUXAN infusion.

Print Page
 

Sign up for updates

Keep up to date on Rituxan Nurse Center material.

Rituxan Nurse Center

The Rituxan.com Nurse Center provides helpful resources and information about Rituxan for RA. To access the Nurse Center features, including a Resource Library, Patient Discussion Guide and Infusion Guide, click on any of the icons below.

  • Resource Library icon Resource Library

    The Resource Library features brochures and other resources focused on Rituxan and RA, and allows you to create customized resource packets that can be printed out or emailed to colleagues and patients.

  • Discussion Guide icon Discussion Guide

    The Patient Discussion Guide provides information designed to help you prepare your patients for Rituxan therapy. This feature also allows you to create a customized Discussion Guide tailored to your patients' specific needs.

  • Infusion Guide icon Infusion Guide

    The Rituxan Infusion Guide provides step-by-step instructions for the administration of Rituxan, and includes a supply list, adverse event information, information about managing severe reactions and a drip-rate table to help you calculate infusion concentrations.